Silo Pharma Inc. (NASDAQ: SILO) Stock Information | RedChip

Silo Pharma Inc. (NASDAQ: SILO) Listen to this Section


$1.51
+0.1500 ( +11.03% ) 225.9K

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Market Data


Open


$1.51

Previous close


$1.36

Volume


225.9K

Market cap


$6.68M

Day range


$1.34 - $1.54

52 week range


$0.84 - $4.50

Insider Ownership Transactions

Total Amount Purchased: 12,420.00 | $ 18,754.20

Date Type Amount Purchased Purchaser
2024-06-13 Buy 562.00 Weisblum Eric
2024-04-08 Buy 600.00 Weisblum Eric
2024-04-01 Buy 3408.00 Weisblum Eric
2023-12-21 Buy 500.00 Weisblum Eric
2023-12-18 Buy 200.00 Weisblum Eric
2023-12-07 Buy 600.00 Weisblum Eric
2023-11-30 Buy 1000.00 Weisblum Eric
2023-11-27 Buy 400.00 Weisblum Eric
2023-11-22 Buy 4050.00 Weisblum Eric
2023-11-20 Buy 1100.00 Weisblum Eric

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 64 Aug 13, 2024
8-k 8K-related 21 Jul 22, 2024
8-k 8K-related 15 Jul 08, 2024
8-k 8K-related 14 Jun 27, 2024
4 Insider transactions 1 Jun 13, 2024
8-k 8K-related 22 Jun 06, 2024
8-k 8K-related 14 Jun 04, 2024
10-q Quarterly Reports 59 May 13, 2024
4 Insider transactions 1 Apr 08, 2024
8-k 8K-related 13 Apr 05, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.